Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0149871 (deep vein thrombosis)
 12,364 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thrombus uptake values of several 99mTc labeled radiocolloids determined using an experimental rodent model of deep venous thrombosis were correlated with particle size distributions. The thrombus uptake values increased with increasing mean particle size. The 99mTc-tin colloid had the highest thrombus uptake value of any of the colloids used in this study.
 ...
PMID:Evaluation of radiocolloids as thrombus imaging agents. Effect of particle size on thrombus uptake. 383 23

Resolution of thrombi entrapped in Greenfield vena caval filters is a primary mechanism for maintenance of caval patency with this device following an embolic event. In order to determine if anticoagulation is beneficial in this setting, thrombus was harvested from 65 mongrel dogs with infrarenal IVC thrombosis after phenolization. These thrombi were weighed and embolized into Greenfield filters placed above the renal veins. The infrarenal IVCs were then ligated and the animals allowed to recover. Beginning the first postoperative day, animals were given either oral coumadin daily to elevate the prothrombin time above 1.5 normal, subcutaneous heparin 500 u/kg/day divided into two doses, or received no treatment. They were sacrificed either 1, 2, 3, or 4 weeks after embolism and the residual thrombi weighed. Initial thrombus weights were similar for each period (differences NS). Comparison of initial with final weights revealed that both coumadin and heparin-treated animals had a significantly increased resolution in the first week when compared to controls. By 2 weeks, however, there were no significant differences between the groups, and controls proceeded to a mean of 95% resolution by 4 weeks. A general linear model used to separate the effects of treatment, time, and initial thrombus weight showed that resolution was primarily a function of initial thrombus weight, and of time. Coumadin was marginally beneficial. Thrombus resolution proceeds rapidly in this model without anticoagulation. These data suggest that prevention of deep vein thrombosis and its sequelae remain the sole indication for anticoagulation after filter placement.
 ...
PMID:Effect of anticoagulation on the lysis of filter entrapped thromboembolism in dogs. 399 33

The diagnostic efficiency of autologous 111In-labelled platelets (ILP) as a scanning agent in deep vein thrombosis (DVT) was investigated in 24 South African baboons (Papio ursinus). Thrombi were surgically induced by stasis, intimal injury and the injection of thrombin in the common femoral veins of adult baboons. The thrombi were allowed to age for 1, 2, 4, 8, 24, 48 and 72 h before injecting the ILP. Scanning was done with a large field gamma camera at 10 min post injection and again at 2, 4, 6, 8, 10, 14, 24, 48 and 72 h. Time-activity curves were thus obtained and it was possible to establish an optimal time after injection of the ILP to scan for each group of thrombi. The results indicate that only the younger thrombi (1-8 h after thrombus formation) were detected. Twenty-four hour and older thrombi were not visualised. A favourable time to scan in the case of the younger thrombi appeared to be approximately 20 h after the injection of ILP. However, the thrombus age limitation still impairs the diagnostic efficiency of the procedure.
 ...
PMID:Evaluation of the diagnostic efficacy of autologous 111In-labelled platelets as a scanning agent for deep vein thrombosis in the chacma baboon. 400 84

Upon reviewing the case records of 177 patients with Hodgkin's disease, we identified ten patients (6%) with deep vein thromboses confirmed by diagnostic tests. Most of the patients initially presented with advanced Hodgkin's disease as defined by stage and constitutional symptoms. Thrombotic episodes usually occurred between cycles of chemotherapy in the absence of clinically detectable tumor. Infusion of chemotherapeutic vesicants may have contributed to the high proportion of upper extremity deep venous thrombosis in this series. Thrombotic episodes did not necessarily imply recurrent disease. Three patients developed thromboses after completion of therapy and remained free of Hodgkin's disease or other malignancies at 85+, 18+, and 17+ months of follow-up.
 ...
PMID:Deep venous thrombosis during therapy for Hodgkin's disease. 402 33

Five patients with deep vein thrombosis were given streptokinase. Five others with similar phlebograms were given anticoagulants, and the results assessed by examining changes in the iliac, femoral, and calf segments of the phlebograms when repeated 7-10 days later. Those of the anticoagulant group were unchanged. Four of the five given streptokinase had a reduction in the size and extent of their thrombosis. Fresh thrombus surrounded by flowing blood was lysed. Thrombus completely blocking a vein was not lysed.The indications for the use of streptokinase in deep vein thrombosis are reviewed.
 ...
PMID:Streptokinase and deep vein thrombosis. 567 63

This review examines the incidence, natural history, diagnosis, prophylaxis, and management of deep vein thrombosis (DVT) and pulmonary embolism (PE) in neurosurgical patients. Recent studies estimate the incidence of postoperative DVT detected by fibrinogen scanning in neurosurgical patients to be 29% to 43%. Specific factors that enhance the risk of venous thromboembolism include previous DVT, surgery, immobilization, advanced age, obesity, limb weakness, heart failure, and lower extremity trauma. Clinical diagnosis of venous thromboembolism is unreliable but can be augmented by noninvasive screening tests such as iodine-125-fibrinogen scanning, Doppler ultrasonography, and impedance plethysmography. As prophylactic measures, mini-dose heparin and external pneumatic compression of the legs have decreased the incidence of DVT in clinical studies of neurosurgical patients. However, no prophylactic measure has been convincingly shown to prevent PE in neurosurgical patients. Thrombi involving the popliteal, deep femoral, and iliac veins appear most likely to cause significant PE. Anticoagulation therapy constitutes standard management of DVT and PE; however, in neurosurgical patients the potential for precipitating intracranial or intraspinal hemorrhage may necessitate vena caval interruption. This appears to be an effective alternative to anticoagulation.
 ...
PMID:Deep vein thrombosis and pulmonary emboli in neurosurgical patients: a review. 638 85

In order to determine the incidence of pre-operative and postoperative deep venous thrombosis (DVT) in patients not receiving prophylactic anticoagulant therapy, bilateral phlebography was performed in a prospective study pre-operatively and on the 9th postoperative day, in 51 consecutive patients submitted for major abdominal surgery. The presence of a DVT before surgery was demonstrated in 15.7 per cent of the patients. This high frequency confirms objectively the rationale of starting prophylactic anticoagulant therapy before the surgical procedure. Thrombi were demonstrated postoperatively by phlebography in 54.9 per cent of the patients. Thus the true incidence of DVT induced by surgery was 39.2 per cent taking into account the 15.7 per cent pre-operative DVT rate.
 ...
PMID:Incidence of pre-operative deep venous thrombosis in abdominal surgery. 647 72

A jugular vein was exposed in 20 cats divided into four groups of five cats each. In group 1 the vein was removed immediately after exposure. In group 2 the vein was removed after three 5-minute periods of stasis and reflow. Groups 3 and 4 had the jugular vein occluded for 24 and 72 hours, respectively. In all groups, veins were perfused under physiologic pressure by heparinized saline to remove blood and immersed in 2.5% glutaraldehyde for fixation. All vessels were prepared for scanning and transmission electron microscopy. Group 1 cats had a normal-appearing luminal surface. Group 2 cats had deposition of leukocytes with few erythrocytes or platelets. Groups 3 and 4 had deposition of leukocytes, platelets, and erythrocytes. Leukocytes were found in all areas and associated with all cell types. Platelets and erythrocytes were seldom found in the absence of leukocytes. Thrombi were found on normal-appearing and damaged endothelium. The majority of thrombi were found at side branches and valve pockets. Our results suggest that leukocytes play a primary role in the initiation of deep vein thrombosis. Platelets may have only a secondary role.
 ...
PMID:Early events in the formation of a venous thrombus following local trauma and stasis. 674 15

The dynamic loss modulus of clotting whole blood was measured in thrombotic patients to characterize the physical properties of coagulation in the hypercoagulable state. The dynamic loss modulus was measured by a Sonoclot. Thrombotic patients consisted of 30 with deep vein thrombosis and 25 with arterial thrombosis. An accelerated increment rate of the dynamic loss modulus at the beginning of gelling was the characteristic of hypercoagulability. This characteristic occurred more frequently than other abnormalities in other tests for hypercoagulability (beta-thromboglobulin, antithrombin III and TEG). Only in deep vein thrombosis, a moderately positive correlation was noted between the increment rate of the dynamic loss modulus and the plasma fibrinogen level.
 ...
PMID:Detection of hypercoagulability by the measurement of the dynamic loss modulus of clotting blood. 713 52

The occurrence of a "rebound hypercoagulable state" in patients after dicontinuation of oral anticoagulants is still a matter of debate and no definite recommendation can be made on the best procedure for anticoagulant withdrawal. The present study investigated the changes in the levels of markers of activated blood coagulation in 32 patients (pts) in whom warfarin treatment (for venous thromboembolic disease) was randomly withdrawn abruptly (n = 17, group A) or gradually (n = 15, group B: 2/3 of initial dose the 1st week, 1/3 the 2nd weeks and nothing from the 3rd week on). Blood was sampled at baseline, once a week for the first three weeks and after 2 months. At the 1st week group A had significantly higher F1+2 and TAT values (p < 0.001); at the 2nd week F1+2 levels remained higher (p < 0.05) though INR values were not different from those of group B. After baseline, higher than normal F1+2 levels were recorded in 32/66 (48%) controls in group A vs 15/60 (25%) in group B (p < 0.01); at the 2nd week, 10/17 (59%) patients in group A vs 1/15 (7%) in group B still had higher than normal F1+2 levels (p < 0.01). The values of areas under curve (AUC) and maximum concentrations of all variables were not statistically different in the two groups; however, very high levels were observed in a few cases of group A. Thrombotic events (one DVT recurrence and one thrombophlebitis in a varicose vein) occurred in 2 pts of group A, both with high F1+2 and TAT AUC values.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study. 783 56


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>